PolyNovo Limited (CALZF)
USD 0.68
(0.07%)
USD 0.68
(0.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 34.92 Million AUD | 282.93% |
| 2023 | 25.51 Million AUD | -35.39% |
| 2022 | 39.49 Million AUD | 28.44% |
| 2021 | 30.75 Million AUD | 25.04% |
| 2020 | 24.59 Million AUD | 47.98% |
| 2019 | 16.61 Million AUD | 32.62% |
| 2018 | 12.53 Million AUD | 19.53% |
| 2017 | 10.48 Million AUD | 37.04% |
| 2016 | 7.65 Million AUD | 92.61% |
| 2015 | 3.97 Million AUD | -4.75% |
| 2014 | 4.17 Million AUD | 21.85% |
| 2013 | 3.42 Million AUD | -20.65% |
| 2012 | 4.31 Million AUD | 1.2% |
| 2011 | 4.26 Million AUD | 27.15% |
| 2010 | 3.35 Million AUD | 12.69% |
| 2009 | 2.97 Million AUD | -44.93% |
| 2008 | 5.4 Million AUD | -61.34% |
| 2007 | 13.96 Million AUD | 10.99% |
| 2006 | 12.58 Million AUD | 8.88% |
| 2005 | 11.55 Million AUD | -6.51% |
| 2004 | 12.36 Million AUD | 33.76% |
| 2003 | 9.24 Million AUD | 128.76% |
| 2002 | 4.04 Million AUD | 40300.0% |
| 2001 | 10 Thousand AUD | 100.28% |
| 2000 | -3.55 Million AUD | -118.08% |
| 1999 | -1.62 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 24.15 Million AUD | 44.05% |
| 2024 FY | 34.92 Million AUD | 36.86% |
| 2024 Q1 | 19.85 Million AUD | 63.38% |
| 2024 Q4 | 24.15 Million AUD | 0.0% |
| 2024 Q2 | 16.76 Million AUD | -15.56% |
| 2023 Q1 | 14.15 Million AUD | 56.05% |
| 2023 Q4 | 12.15 Million AUD | -20.5% |
| 2023 Q3 | 15.28 Million AUD | 17.66% |
| 2023 Q2 | 12.99 Million AUD | -8.21% |
| 2023 FY | 25.51 Million AUD | -35.39% |
| 2022 Q2 | 7.31 Million AUD | 11.89% |
| 2022 Q3 | 10.85 Million AUD | 48.35% |
| 2022 Q4 | 9.07 Million AUD | -16.39% |
| 2022 Q1 | 6.53 Million AUD | -2.24% |
| 2022 FY | 39.49 Million AUD | 28.44% |
| 2021 Q2 | 4.4 Million AUD | -37.53% |
| 2021 Q3 | 7.13 Million AUD | 62.2% |
| 2021 FY | 30.75 Million AUD | 25.04% |
| 2021 Q4 | 6.68 Million AUD | -6.32% |
| 2021 Q1 | 7.04 Million AUD | 69.56% |
| 2020 Q4 | 4.15 Million AUD | -30.09% |
| 2020 Q1 | 5.14 Million AUD | 26.5% |
| 2020 Q2 | 4.46 Million AUD | -13.18% |
| 2020 Q3 | 5.94 Million AUD | 32.95% |
| 2020 FY | 24.59 Million AUD | 47.98% |
| 2019 FY | 16.61 Million AUD | 32.62% |
| 2019 Q4 | 4.06 Million AUD | 8.79% |
| 2019 Q3 | 3.74 Million AUD | 34.96% |
| 2019 Q2 | 2.77 Million AUD | -0.0% |
| 2019 Q1 | 2.77 Million AUD | 32.63% |
| 2018 Q4 | 2.08 Million AUD | 0.0% |
| 2018 FY | 12.53 Million AUD | 19.53% |
| 2018 Q3 | 2.08 Million AUD | -0.12% |
| 2018 Q2 | 2.09 Million AUD | -0.0% |
| 2018 Q1 | 2.09 Million AUD | 0.04% |
| 2017 Q3 | 2.09 Million AUD | 32.17% |
| 2017 Q2 | 1.58 Million AUD | -0.0% |
| 2017 Q1 | 1.58 Million AUD | 43.18% |
| 2017 FY | 10.48 Million AUD | 37.04% |
| 2017 Q4 | 2.09 Million AUD | 0.0% |
| 2016 Q3 | 1.1 Million AUD | -16.9% |
| 2016 FY | 7.65 Million AUD | 92.61% |
| 2016 Q4 | 1.1 Million AUD | 0.0% |
| 2016 Q2 | 1.33 Million AUD | 0.0% |
| 2016 Q1 | 1.33 Million AUD | 911.95% |
| 2015 Q3 | 131.43 Thousand AUD | -83.56% |
| 2015 Q1 | 799.26 Thousand AUD | -1.6% |
| 2015 Q2 | 799.26 Thousand AUD | -0.0% |
| 2015 FY | 3.97 Million AUD | -4.75% |
| 2015 Q4 | 131.43 Thousand AUD | 0.0% |
| 2014 Q3 | 812.29 Thousand AUD | 13.61% |
| 2014 Q2 | 714.97 Thousand AUD | -0.0% |
| 2014 FY | 4.17 Million AUD | 21.85% |
| 2014 Q1 | 714.97 Thousand AUD | 14.32% |
| 2014 Q4 | 812.29 Thousand AUD | 0.0% |
| 2013 FY | 3.42 Million AUD | -20.65% |
| 2013 Q2 | 661.93 Thousand AUD | -0.0% |
| 2013 Q1 | 661.93 Thousand AUD | 0.0% |
| 2013 Q4 | 625.41 Thousand AUD | 0.0% |
| 2013 Q3 | 625.41 Thousand AUD | -5.52% |
| 2012 FY | 4.31 Million AUD | 1.2% |
| 2011 FY | 4.26 Million AUD | 27.15% |
| 2010 FY | 3.35 Million AUD | 12.69% |
| 2009 FY | 2.97 Million AUD | -44.93% |
| 2008 FY | 5.4 Million AUD | -61.34% |
| 2007 FY | 13.96 Million AUD | 10.99% |
| 2006 FY | 12.58 Million AUD | 8.88% |
| 2005 FY | 11.55 Million AUD | -6.51% |
| 2004 FY | 12.36 Million AUD | 33.76% |
| 2003 FY | 9.24 Million AUD | 128.76% |
| 2002 FY | 4.04 Million AUD | 40300.0% |
| 2001 FY | 10 Thousand AUD | 100.28% |
| 2000 FY | -3.55 Million AUD | -118.08% |
| 1999 FY | -1.62 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Avitar, Inc. | 3.56 Million USD | -878.341% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -2544.612% |
| Polarean Imaging plc | 12.24 Million USD | -185.253% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 4.89 Million USD | -613.568% |
| BioElectronics Corporation | 740.67 Thousand USD | -4614.882% |
| AVITA Medical, Inc. | 80.77 Million USD | 56.769% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -4867.568% |
| Össur hf. | 396.18 Million USD | 91.185% |
| Zecotek Photonics Inc. | 3.46 Million USD | -908.885% |
| QHSLab, Inc. | 961.65 Thousand USD | -3531.455% |
| Wellstar International, Inc. | 1.79 Million USD | -1845.845% |
| Össur hf. | 396.18 Million USD | 91.185% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | -60.354% |
| Escalon Medical Corp. | 5.25 Million USD | -565.096% |
| Aurora Spine Corporation | 8.65 Million USD | -303.373% |
| BrainsWay Ltd. | 28.01 Million USD | -24.641% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | -265.127% |
| Hamilton Thorne Ltd. | 33.57 Million USD | -4.019% |
| Vivos Inc. | 2.78 Million USD | -1152.982% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 96.669% |
| Kelyniam Global, Inc. | 2.27 Million USD | -1434.868% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -3340.92% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -7918.829% |
| Nanomix Corporation | 8.36 Million USD | -317.342% |
| Theraclion SA | 7.43 Million USD | -369.392% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -2597.559% |
| Positron Corporation | 1 Million USD | -3366.943% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -1022.733% |
| Lombard Medical, Inc. | 30.29 Million USD | -15.292% |
| ALR Technologies Inc. | 6.33 Million USD | -451.168% |
| Stratec SE | 46.32 Million USD | 24.608% |
| Vycor Medical, Inc. | 1.27 Million USD | -2637.986% |
| Heart Tronics, Inc. | 14.46 Million USD | -141.506% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -28874.661% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -16818.016% |
| SANUWAVE Health, Inc. | 14.15 Million USD | -146.781% |
| VMS Rehab Systems, Inc. | 63.63 USD | -54882816.863% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -899.771% |
| Ingen Technologies, Inc. | 1.88 Million USD | -1755.361% |
| Odyssey Group International, Inc. | -14.26 Million USD | 344.876% |
| United American Healthcare Corporation | 59 Thousand USD | -59089.831% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -8470.131% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -5402.231% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -1959.608% |
| Urologix, Inc. | 10.09 Million USD | -246.036% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -2664.275% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -487.092% |
| SS Innovations International, Inc. | 21.38 Million USD | -63.326% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -15067.585% |
| Smith & Nephew plc | 3.46 Billion USD | 98.993% |
| NIOX Group Plc | 22.27 Million USD | -56.759% |
| Fuse Medical, Inc. | 10.35 Million USD | -237.41% |
| Broncus Holding Corporation | 38.15 Million USD | 8.464% |
| Brain Scientific Inc. | 9.66 Million USD | -261.409% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -238.952% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -57434.021% |